Incidence and predictors of severe liver fibrosis in human immunodeficiency virus-infected patients with chronic hepatitis C: a European collaborative study.
about
The treatment of patients with HIVDiminished frequency of hepatitis C virus specific interferon secreting CD4+ T cells in human immunodeficiency virus/hepatitis C virus coinfected patientsProvider and patient correlates of provider decisions to recommend HCV treatment to HIV co-infected patientsTreatment of chronic hepatitis C in HIV-infected patients with compensated liver cirrhosis.The French national prospective cohort of patients co-infected with HIV and HCV (ANRS CO13 HEPAVIH): early findings, 2006-2010.Rapid development of advanced liver fibrosis after acquisition of hepatitis C infection during primary HIV infection.TRAIL dependent fratricidal killing of gp120 primed hepatocytes by HCV core expressing hepatocytes.Hepatitis C virus infection in the human immunodeficiency virus infected patient.Evaluating Liver Fibrosis by Transient Elastometry in Patients With HIV-HCV Coinfection and Monoinfection.HIV-1 tropism and liver fibrosis in HIV-HCV co-infected patientsKupffer cells are depleted with HIV immunodeficiency and partially recovered with antiretroviral immune reconstitution.Prevalence and epidemiological correlates and treatment outcome of HCV infection in an Italian prison setting.Predictors of Weight Change in Male HIV-Positive Injection Drug Users Initiating Antiretroviral Therapy in Hanoi, Vietnam.Cystatin C and creatinine in an HIV cohort: the nutrition for healthy living study.The influence of treatment with pegylated interferon-alfa and ribavirin on neutrophil function and death in patients with HIV/HCV coinfection.New hopes for HIV and HCV coinfection in 2004.The influence of HAART on the efficacy and safety of pegylated interferon and ribavirin therapy for the treatment of chronic HCV infection in HIV-positive Individuals.Dysregulation of innate immunity in hepatitis C virus genotype 1 IL28B-unfavorable genotype patients: impaired viral kinetics and therapeutic response.HCV Specific IL-21 Producing T Cells but Not IL-17A Producing T Cells Are Associated with HCV Viral Control in HIV/HCV CoinfectionTreatment of hepatitis C in HIV-coinfected patients.Hepatic steatosis is associated with fibrosis, nucleoside analogue use, and hepatitis C virus genotype 3 infection in HIV-seropositive patients.PharmGKB summary: peginterferon-α pathway.Expanding research on the role of alcohol consumption and related risks in the prevention and treatment of HIV/AIDS.Triple positivity of HBsAg, anti-HCV antibody, and HIV and their influence on CD4+ lymphocyte levels in the highly HIV infected population of Abeokuta, Nigeria.Clinical Liver Disease Progression Among Hepatitis C-Infected Drug Users With CD4 Cell Count Less Than 200 Cells/mm(3) Is More Pronounced Among Women Than Men.The role of viral co-infection in HIV-associated non-AIDS-related cancersAssociation of a single nucleotide polymorphism near the interleukin-28B gene with response to hepatitis C therapy in HIV/hepatitis C virus-coinfected patients.Impact of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis.Substance Abuse, Hepatitis C, and Aging in HIV: Common Cofactors that Contribute to Neurobehavioral Disturbances.Liver disease in injection drug users with hepatitis C, with and without HIV coinfection.Predictors of complication after percutaneous ultrasound-guided kidney biopsy in HIV-infected individuals: possible role of hepatitis C and HIV co-infection.Cancer risk in HIV-infected persons: influence of CD4(+) count.The treatment of chronic hepatitis C virus infection in HIV co-infection.Interferon combination therapy for HIV/hepatitis C virus coinfection.Update on HIV/HCV coinfection.Ombitasvir/paritaprevir/ritonavir and dasabuvir tablets for hepatitis C virus genotype 1 infection.Liver stiffness is not associated with short- and long-term plasma HIV RNA replication in immunocompetent patients with HIV infection and with HIV/HCV coinfection.Fibrosis progression in paired liver biopsies from HIV/HCV co-infected patients.How to optimize hepatitis C virus treatment impact on life years saved in resource-constrained countries.Comparison of laboratory tests, ultrasound, or MRE to detect fibrosis in patients with non-alcoholic fatty liver disease: A meta-analysis.
P2860
Q24597485-3D632F91-D9D4-4A83-9960-F6520B832FD0Q27477581-07B9B1D6-1A53-46BE-AB96-28E524395B8AQ30416486-61378165-56E3-4283-A072-53C464A818ABQ33391761-A97ECF78-B9BB-46EA-9B3D-F85D3B292B76Q33726091-C845666C-197D-41EB-93BA-2B67591530EAQ33889225-AB948943-F99E-4742-BD2A-369F97D12DCEQ34081462-0EFD9A53-DFEE-43B5-88E5-B9796BFAA313Q34168504-88BCAC24-372E-496A-907B-711C8FA553CEQ34349036-499BE1BE-BC5D-47FB-998F-AB0EA0282492Q34505231-E2F31237-E77B-43B8-9BEE-7C4A014B7DA1Q34974095-A3924749-1433-4DE5-AE27-97B3BA4081D8Q35020696-F021008E-B097-44D2-9E37-51AB80616D28Q35110006-AEE89251-FCA6-43F6-82A9-B05B8BFD8F28Q35604023-D32DBA21-4FE5-45E1-83DE-F989CEFB839CQ35866167-6E95B684-D76B-4FCD-A93D-317521AE570FQ35912407-D1461152-0456-4C78-AC5B-6215AED40E83Q35960026-58AA83AC-C423-4B35-AA2B-53100C9CA629Q35992420-9D0944DC-6EF0-4B37-A922-591EAC1D1712Q36001951-7B819277-E510-490D-BFCA-C60C4E972005Q36409500-1A7FFCC9-1D50-4256-B9BA-9F0597E520D3Q36521414-AF52149D-31F5-4B80-BE06-D18C2DBA523EQ36590755-5ECC7D25-6FE3-4DFD-9622-E62BEA4A8C4EQ36604542-3165B8AA-7F4F-4FA7-BE5C-5F43AF63579FQ36612848-76E435D2-3501-471B-AFB8-ADCA735848E4Q36650557-9B5BC518-E38C-4D59-AD9A-72F42F81DE46Q36960884-C16A3742-AC1B-4569-947E-18B40A4B72ECQ36967081-D8F389DE-9D43-4935-869A-1BB9BE07F8D7Q37122490-7922D068-D829-4E0E-85E5-309C6DAF687EQ37149288-D64FA629-5BFC-43DA-99C6-76B229D2AB9BQ37235533-2E0363AC-F8A0-42B7-81E5-E5D443F12401Q37415707-AB4BBD93-19D5-4977-8A7A-F6FA3B0C3D24Q37515370-8036893C-2365-4D41-B0C8-178751FBA9E4Q37691055-D5E51F58-D0D1-4541-AEE7-286B899638CEQ37931258-447EB892-CF0D-4C26-A06A-2638B1A71002Q38119893-CE3A01E2-BB78-4AB6-A717-2D0FCE626E38Q38355057-113A6BA7-57FE-4A6D-9738-0F7D08BA7E20Q38606313-7F50D834-2910-4D76-9104-9B1C15FC0F4DQ39018310-D864492C-72DF-45AF-BD09-E9A90A6C162DQ39315196-1E84A3A8-1B8F-46F0-845A-E7FAAE848AAEQ39354122-DF9675DC-2BDA-4268-84C6-738E18267BED
P2860
Incidence and predictors of severe liver fibrosis in human immunodeficiency virus-infected patients with chronic hepatitis C: a European collaborative study.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Incidence and predictors of se ...... European collaborative study.
@en
Incidence and predictors of se ...... European collaborative study.
@nl
type
label
Incidence and predictors of se ...... European collaborative study.
@en
Incidence and predictors of se ...... European collaborative study.
@nl
prefLabel
Incidence and predictors of se ...... European collaborative study.
@en
Incidence and predictors of se ...... European collaborative study.
@nl
P2093
P356
P1476
Incidence and predictors of se ...... European collaborative study.
@en
P2093
Ana Arizcorreta
Antonio Gonzalez
Carmen Quereda
Javier García-Samaniego
José Antonio Girón
José Mallolas
Juan Berenguer
Juan José de la Cruz
Leonor Moreno
Luz Martín-Carbonero
P304
P356
10.1086/380130
P407
P577
2003-12-08T00:00:00Z